Skip to content

Exactech: owners, implant recalls and bankruptcy

The Hospital for Special Surgery and the femoral components

The Hospital for Special Surgery in New York had worked with Exactech since 1992 and licensed it the Optetrak knee. The Settlement Trust alleges that HSS reported badly worn, oxidised polyethylene from 2017, that William Petty, at Jeffrey Binder's direction, urged HSS surgeons in 2018 not to present their data, and that HSS stopped buying Exactech knees in 2019 and shoulders in 2021. The trust also says Exactech made femoral knee components to a wrong surface specification for years. Binder and TPG say the packaging problem was discovered in 2021; the allegations have not been adjudicated.

published
23 oct 2026
records as of
16 oct 2026
entities
178
sources
112
cite entities.csv

the questionWhat did the Hospital for Special Surgery report about Exactech’s implants, and how did Exactech respond?

1A long collaboration

analysisThe Judicial Panel on Multidistrict Litigation noted the plaintiffs' point that the Hospital for Special Surgery, where witnesses on the Optetrak knee were located, had a collaborative relationship with Exactech since 1992. 1

sources in this section

  1. JPML transfer order, In re Exactech Polyethylene Orthopedic Products Liability Litigation, MDL No. 3044 U.S. Judicial Panel on Multidistrict Litigation · 7 Oct 2022

2What HSS reported, according to the trust

analysisThe complaint states that on August 4, 2017 HSS told Gary Miller of a "badly worn GXL acetabular insert" that seemed to have oxidised considerably more than other makers' crosslinked polyethylene, apparently the first of its oxidation complaints. It alleges that in October 2018, with Binder's direction, William Petty emailed several HSS surgeons a letter warning that presenting data on delamination and oxidation of Exactech polyethylene would damage both institutions and urging HSS to withdraw the presentation, and that HSS removed all Exactech PS knee implants from its inventory on February 9, 2019 and pulled the Equinoxe shoulder on February 17, 2021, having implanted over 15,000 Exactech moulded polyethylene inserts in 20 years. The trust alleges that Binder, Schilling and other TPG defendants sought to deter HSS from disclosing the problems and to conceal what the board and TPG knew as early as 2018, delaying the recalls. These are allegations in the Settlement Trust’s pending complaint and have not been adjudicated. TPG has denied wrongdoing, and Binder has said that Exactech discovered the packaging non-conformity in 2021 through its own complaint investigations and reported it to FDA. 1

sources in this section

  1. Court record source · src-012 identified by category only · Court record

3The femoral component specification

analysisThe complaint states that the unsecured creditors' committee found that from late 2004 until November 17, 2021 Exactech made femoral knee components to an incorrect non-articulating surface roughness specification, potentially affecting up to 371,986 devices, while outside manufacturers had read the ambiguous specification correctly, and that a March 31, 2021 health hazard evaluation confirmed that cement de-bonding was likely caused by a finish too smooth for the cement to hold. These are allegations in the Settlement Trust’s pending complaint and have not been adjudicated. No response by Exactech, TPG or Binder on this issue was found in the retained records. 1

sources in this section

  1. Court record source · src-012 identified by category only · Court record

cite this dossier

DossierTwist, “Exactech: owners, implant recalls and bankruptcy”, dt.017, 23 October 2026, https://dossiertwist.com/dossiers/exactech/

Free to read, cite and republish with credit under CC BY 4.0: credit “DossierTwist” and link to the dossier.

Data: JSON, CSV and the network graph.

We listen to all sides: responses are shown next to the claims they answer. To send a correction or a reply, write to dossiertwist@proton.me.